The XGBoost model predicts hyperglycemia risk in psoriasis patients with high accuracy, achieving an AUC of 0.821 in the training set. A web-based calculator was developed to facilitate personalized ...
Feasibility and efficacy of a pharmacist-led video consultation to identify drug interactions among patients initiating oral anti-cancer drugs. This is an ASCO Meeting Abstract from the 2023 ASCO ...
Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has demonstrated that it can predict the outcome of Phase II to Phase III ...